American biotechnology company in New Jersey working on medicines against antimicrobial resistance. Develops small molecules aimed at bacterial targets that resistant Gram negative organisms depend on, including inhibitors of protein secretion and cell division machinery, runs preclinical programmes against hospital pathogens, and has been supported by federal research grants and academic collaborations.
No hay comentarios disponibles.
Deja tu valoración & comentario